Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

News und Analysen

CI Financial Announces Commencement of Consent Solicitation and Notice of Debentureholder Meetings
CI Financial Announces Commencement of Consent Solicitation and Notice of Debentureholder Meetings


CI Financial Corp. (TSX: CIX) (“CI Financial” or the “Corporation”) announced today it has called a meeting of the (i) holders (the “2025 Debentureholders”) of its 3.759% Debentures due 2025 (the “

GenSight Biologics Announces LUMEVOQ® Scientific Updates at NANOS 2024
GenSight Biologics Announces LUMEVOQ® Scientific Updates at NANOS 2024


Regulatory News:



GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on discovering and developing innovative gene therapies for retinal

EQS-News: Befesa delivered €182m adjusted EBITDA despite a persistently challenging year 2023
EQS-News: Befesa delivered €182m adjusted EBITDA despite a persistently challenging year 2023
EQS-News: Befesa delivered €182m adjusted EBITDA despite a persistently challenging year 2023
Granite Announces Fourth Quarter and Year End Results for 2023 and the Appointment of a New Trustee
Granite Announces Fourth Quarter and Year End Results for 2023 and the Appointment of a New Trustee


Granite Real Estate Investment Trust and Granite REIT Inc. (TSX: GRT.UN; NYSE: GRP.U) (“Granite” or the “Trust”) announced today its combined results for the three month period and year ended

Vistagen to Present at TD Cowen 44th Annual Health Care Conference
Vistagen to Present at TD Cowen 44th Annual Health Care Conference


Vistagen (Nasdaq: VTGN), a biopharmaceutical company pioneering neuroscience to deliver groundbreaking therapies for individuals affected by psychiatric and neurological disorders, today announced

Fuel Tech Schedules 2023 Fourth Quarter and Full Year Financial Results and Conference Call
Fuel Tech Schedules 2023 Fourth Quarter and Full Year Financial Results and Conference Call


Fuel Tech, Inc. (NASDAQ: FTEK), a technology company providing advanced engineering for the optimization of combustion systems, emissions control, and water treatment in utility and industrial

CI Financial Announces Commencement of Substantial Issuer Bid
CI Financial Announces Commencement of Substantial Issuer Bid


CI Financial Corp. (TSX: CIX) (“CI Financial” or the “Corporation”) announced today it has commenced its previously announced substantial issuer bid (the “Offer”), pursuant to which the Corporation

CI Financial Reports Financial Results for the Fourth Quarter of 2023
CI Financial Reports Financial Results for the Fourth Quarter of 2023


CI Financial Corp. (“CI”) (TSX: CIX) today released financial results for the quarter and year ended December 31, 2023.



“Strong fourth quarter results capped a successful year for CI, with

CI Global Asset Management Expands Alternative Funds Lineup with Launch of CI Auspice Alternative Diversified Corporate Class
CI Global Asset Management Expands Alternative Funds Lineup with Launch of CI Auspice Alternative Diversified Corporate Class


CI Global Asset Management (“CI GAM”) announces the launch of CI Auspice Alternative Diversified Corporate Class (“the Fund”), a systematic, trend-following, multi-strategy mandate designed to

CI Financial Reports Total Assets of $450.8 Billion for January 2024
CI Financial Reports Total Assets of $450.8 Billion for January 2024


CI Financial Corp. (“CI”) (TSX: CIX) today reported preliminary total assets of $450.8 billion as at January 31, 2024, consisting of asset management assets of $124.8 billion, Canadian wealth

Granite REIT Declares Distribution for February 2024
Granite REIT Declares Distribution for February 2024


Granite Real Estate Investment Trust (“Granite”) (TSX: GRT.UN / NYSE: GRP.U) announced today that its board of trustees has declared a distribution of CDN $0.275 per stapled unit for the month of

ABIONYX Pharma Acknowledges the Clinical Results of the Phase 3 AEGIS-II Study Evaluating the Efficacy and Safety of CSL Behring’s Human-plasma-derived apoA-I, CSL112
ABIONYX Pharma Acknowledges the Clinical Results of the Phase 3 AEGIS-II Study Evaluating the Efficacy and Safety of CSL Behring’s Human-plasma-derived apoA-I, CSL112


Access here the full press release



ABIONYX Pharma, (FR0012616852 – ABNX – PEA PME eligible), a new generation biotech company dedicated to the discovery and development of innovative therapies

CI Global Asset Management Announces February 2024 Distributions for the CI ETFs
CI Global Asset Management Announces February 2024 Distributions for the CI ETFs


CI Global Asset Management (“CI GAM”) announces the following regular cash distributions for the month ending February 29, 2024 in respect of the CI ETFs. In all cases, the distribution will be

Vistagen Reports Fiscal 2024 Third Quarter Financial Results and Provides Corporate Update
Vistagen Reports Fiscal 2024 Third Quarter Financial Results and Provides Corporate Update


Vistagen (Nasdaq: VTGN), a late clinical-stage biopharmaceutical company pioneering neuroscience to deliver first-in-class therapies for psychiatric and neurological disorders, today reported

Fuel Tech Publishes White Paper on Positive Effects of Its Dissolved Gas Infusion Technology in an Aquaculture Setting
Fuel Tech Publishes White Paper on Positive Effects of Its Dissolved Gas Infusion Technology in an Aquaculture Setting


Fuel Tech, Inc. (NASDAQ: FTEK), a technology company providing advanced engineering for the optimization of combustion systems, emissions control, and water treatment in utility and industrial

Vistagen to Report Fiscal Year 2024 Third Quarter Financial Results and Host Corporate Update Conference Call on February 13, 2024
Vistagen to Report Fiscal Year 2024 Third Quarter Financial Results and Host Corporate Update Conference Call on February 13, 2024


Vistagen (NASDAQ: VTGN), a late clinical-stage biopharmaceutical company pioneering neuroscience to deliver first-in-class therapies for psychiatric and neurological disorders, today announced it

CI Global Asset Management Funds Recognized for Consistent, Outstanding Investment Performance
CI Global Asset Management Funds Recognized for Consistent, Outstanding Investment Performance


CI Global Asset Management (“CI GAM”) announces it has received 35 FundGrade A+® Awards for 2023. The winning CI GAM funds include eight mutual funds, six exchange-traded funds and 21 segregated

EQS-News: Medios AG: Supervisory Board extends contracts with members of the Executive Board Mi-Young Miehler and Christoph Prußeit
EQS-News: Medios AG: Supervisory Board extends contracts with members of the Executive Board Mi-Young Miehler and Christoph Prußeit
EQS-News: Medios AG: Supervisory Board extends contracts with members of the Executive Board Mi-Young Miehler and Christoph Prußeit
CI Financial Announces Fourth Quarter Earnings Conference Call and Webcast
CI Financial Announces Fourth Quarter Earnings Conference Call and Webcast


CI Financial Corp. (“CI”) (TSX: CIX) will release its financial results for the fourth quarter of fiscal 2023 on Friday, February 23, 2024.



CI will hold a conference call with analysts that day

CI Global Asset Management Launches Equity Fund Suite Focusing on Quality, Dividends and Growth
CI Global Asset Management Launches Equity Fund Suite Focusing on Quality, Dividends and Growth


CI Global Asset Management (“CI GAM”) announces the launch of a suite of equity mutual funds that target dividend-paying companies with high-quality balance sheets and strong earnings growth

OSE Immunotherapeutics Highlights Clinical Portfolio Advancements and Provides 2024 Outlook
OSE Immunotherapeutics Highlights Clinical Portfolio Advancements and Provides 2024 Outlook


Regulatory News:



OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE) updates on its clinical portfolio advancements and provides 2024 outlook.



Nicolas Poirier, Chief Executive Officer

CI Global Asset Management Expands Access to its Private Pools
CI Global Asset Management Expands Access to its Private Pools


CI Global Asset Management (“CI GAM”) announces it is reducing the minimum initial investment on its lineup of private pools to $5,000 from $25,000, effective today. The CI Private Pools consist of

Granite REIT Declares Distribution for January 2024
Granite REIT Declares Distribution for January 2024


Granite Real Estate Investment Trust (“Granite”) (TSX: GRT.UN / NYSE: GRP.U) announced today that its board of trustees has declared a distribution of CDN $0.275 per stapled unit for the month of

CI Financial Reports Total Assets of $444.8 Billion for December 2023
CI Financial Reports Total Assets of $444.8 Billion for December 2023


CI Financial Corp. (“CI”) (TSX: CIX) today reported preliminary total assets of $444.8 billion as at December 31, 2023, consisting of asset management assets of $125.0 billion, Canadian wealth

CI Global Asset Management Announces January 2024 Distributions for the CI ETFs
CI Global Asset Management Announces January 2024 Distributions for the CI ETFs


CI Global Asset Management (“CI GAM”) announces the following regular cash distributions for the month ending January 31, 2024 in respect of the CI ETFs. In all cases, the distribution will be paid